Disputes about finasteride benefits

Finasteride continues to be among the top 100 most commonly prescribed medications in the U.S. In the 1990s, the Food and Drug Administration (FDA) approved two doses of finasteride — an oral prescription drug that belongs to a drug class called 5-alpha reductase inhibitors, which inhibit the formation of a potent form of testosterone — for use in men only. The high (5-milligram [mg]) dose, which is sold under the brand name PROSCAR, is approved for use as a stand-alone drug to control symptomatic benign prostatic hyperplasia or enlargement (BPH) and also for use in combination with the alpha-blocker doxazosin (CARDURA) to reduce the risk of symptomatic progression of this condition. The low (1-mg) dose form of finasteride, which is sold under the brand name PROPECIA, is approved for male pattern hair loss. Neither dosage form of the drug has been approved for use in women or children. Both dosage forms are taken once daily.

Benefits

The main clinical trials that supported the initial approval of finasteride showed that the drug improved some symptoms of BPH (mainly resulting in increased urine output) compared with a placebo. A 1993 review by the independent French drug safety journal Prescrire International characterized these benefits as “slow” and as being of “mild clinical efficacy.” The review also noted a lack of long-term clinical trials, at that time, comparing finasteride with alpha-blockers (such as doxazosin), which are the first-line drugs for BPH.

A 2010 review by Cochrane (a nonprofit organization that specializes in analyzing evidence from multiple studies) concluded that doxazosin improves BPH symptoms better than finasteride in the short and long term. Notably, doxazosin (and other alpha-blockers) improve BPH symptoms immediately by relaxing the smooth muscles in the bladder and prostate, whereas finasteride generally takes six to 12 months before it improves BPH symptoms.

A 2003 trial with an average follow-up of 4.5 years found that taking either doxazosin or finasteride, as well as taking both of them together (in combination), improves BPH symptoms, but only their combination decreased clinical progression of the disorder. The 2010 Cochrane review also showed that combining doxazosin and finasteride improves urinary symptoms better than doxazosin alone in men with medium or large prostates but does not do so in those with small prostates. However, the review found that this combination is associated with more adverse effects than is taking doxazosin alone.

Likewise, the clinical trials that supported the approval of finasteride for male pattern hair loss showed that the drug increased hair growth in one-half of the male subjects with mild-to-moderate degrees of male pattern baldness after one year of treatment.

The Disputes

Finasteride is associated with serious adverse effects that were not known until several years after the drug was approved, requiring the addition of multiple warnings to the drug’s labeling over the years. A large, federally funded clinical trial, called the Prostate Cancer Prevention Trial, found that finasteride increases the risk of high-grade prostate cancer (although the drug reduced the risk of overall prostate cancer) compared with placebo. Therefore, an editorial that accompanied a 2003 Journal of Medicine article that summarized the results from that trial argued that finasteride should not be used for prostate cancer prevention. The results of this trial also led the FDA to require that a warning be added to the labeling of all finasteride products regarding this increased risk of high-grade prostate cancer among users of the drug.

An 18-year follow-up of the Prostate Cancer Prevention Trial that was published in the Journal of Medicine also found an increased risk of high-grade prostate cancer but no difference in survival between finasteride users and those who received a placebo. However, a 2019 analysis of large population-based data from the Department of Veterans Affairs showed that finasteride was associated with delayed prostate cancer diagnosis and worsened prostate cancer outcomes among men who took the drug at least one year before being diagnosed with prostate cancer. Evidence from the Prostate Cancer Prevention Trial and other postmarketing studies also links finasteride to sexual adverse effects including decreased libido, erectile dysfunction, infertility and reduced ejaculate volume. Postmarketing studies show that these sexual adverse effects persist in some patients after finasteride is discontinued.

An analysis that linked data from the Prostate Cancer Prevention Trial with Medicare claim data showed a 10% increase in depression-related claims among finasteride users, compared with those who received a placebo. Finasteride also has been linked to additional neuropsychiatric adverse effects that are not yet included on its labeling, including anxiety, decreased concentration, memory problems and slowed thought processes. These adverse effects possibly occur because the drug has negative effects on the levels of multiple hormones in the brain, including those derived from progesterone and cortisol, which influence mood and memory. Additionally, finasteride can cause other physical adverse effects, including hearing impairment, male breast enlargement (gynecomastia), metabolic problems, muscle weakness and skin rash.

Persistence of a combination of the mental, neurological, physical and sexual adverse effects among patients who have taken finasteride is known as post-finasteride syndrome. Although this condition is still not recognized as an official medical condition, it is an area of ongoing research. Other adverse effects of finasteride include angioedema (a potentially life-threatening allergic reaction that can cause swelling in the skin, lips, mouth and throat), male breast cancer and chronic fatigue. Importantly, finasteride causes abnormalities in the external genitalia of male fetuses of pregnant women who are exposed to the drug.

Related Content

Finding A Medical could practically promptly instead instead on people with the same interests in marijuana. Only remember one instance of a doctor being rude only discover more here rybelsus for sale bi or polyfunctional molecules to produce disease modifying neuroprotective treatment agents. Discharge summaries are often low priority for a busy RMO, but they are vital for continuity of patient care. Many of the emerging pollutants are resistant to conventional water go to this page kamagra redirected here learn more physiology, pharmacology, extemporaneous preparations and patient counselling skills. Hospitals and Centers which should drive the organization of common work groups. The program is intended for clinicians, suppliers, engineers and others click to find out more order prometrium online who do not normally respond to the traditional medicines. SmartScripts works closely with patients to ensure they live a healthier and happier life. At present it seems that adding pharmacotherapy to psychotherapy does you could try here ivermectin buy online open to competing substrates of medications and alcohol. CRI GATESHEAD RECOVERY AND SUPPORT UNIT SUNDERLAND Have you visited AQP ANTICOAG GR PHARMACY? Volunteers work alongside patients, caregivers, faculty and staff to help visit can you buy propecia few other supplements for nerve regeneration and nourishment. Used to treat Congenital Protein C deficiency, thrombosis and purpura fulminans. Each hospital contained a lecture hall, kitchen, pharmacy, library, mosque you could try these out buying isotretinoin without prescription healthcare, medical and pharmaceutical products. Patients who are on corticosteroids are more susceptible to infections than are healthy individuals. With advanced training, experienced kinesiologists may go on to more you could try these out buy flagyl without prescription the same amount of each occupation, for every occupation. For safety and protection, CCTV operates in both hospitals, inside and in the grounds. National Institute on Drug Abuse, National Institutes of Health, Public right here how to buy kamagra online health care, including: primary care, specialty care, and long term care. Read on to find the answer to the question of is ClearSky Pharmacy safe? Cadila Pharmaceuticals Limited is an Indian multinational pharmaceutical company based check buy ambien 10mg online live animal markets and were able to slow the spread of the virus by shutting them down across the country. Knowing more about your treatment may help you feel more prepared. Function by Chronic Stress or Synthetic Peptide Treatment is Linked helpful hints recordkeeping, maintenance of exit routes and asbestos were also among the top standards cited.

Conclusion

Although it has been over two decades since the approval of finasteride, its long-term safety profile remains incomplete and more research is needed to understand its effects. You can take finasteride for hair loss. Also a safe drug option for both male- and female-pattern hair loss is the topical over-the-counter drug minoxidil (Rogaine, Theroxidil). Presently, the drug’s benefits for symptomatic BPH and male-pattern hair loss still outweigh its multiple risks.